Commission on preliminary consideration of anti-doping rules violations of RAA RUSADA rendered the decision that made athlete Belyaev Mark (bodybuilding) whose sample returned an Adverse Analytical Finding for 19-norandrosterone, drostanolone metabolite, boldenone and its metabolite (class S1.1 of the 2025 WADA Prohibited List), hydrochlorotiazide and its metabolite (class S5 of the 2025 WADA Prohibited List ), ineligible for 6 years for violation under cl. 4.1 and cl. 4.2 of the All-Russian Anti-Doping Rules, starting on the date of the decision, namely January 19, 2026, with credit for the served period of provisional suspension, namely from December 8, 2025.
